Report Overview
Induced pluripotent stem cells (iPSCs) are genetically reprogrammed adult cells that exhibit a pluripotent stem cell-like state similar to embryonic stem cells.1 While these artificially generated cells are not known to exist in the human body, they show qualities remarkably similar to those of embryonic stem cells (ESCs); thus, iPSCs are an invaluable resource for drug discovery, cell therapy, and basic research.
The global Human Induced Pluripotent Stem Cells (iPSCs) market size was estimated at USD 115 million in 2023 and is projected to reach USD 517.91 million by 2032, exhibiting a CAGR of 18.20% during the forecast period.
North America Human Induced Pluripotent Stem Cells (iPSCs) market size was estimated at USD 40.04 million in 2023, at a CAGR of 15.60% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Human Induced Pluripotent Stem Cells (iPSCs) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Induced Pluripotent Stem Cells (iPSCs) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Induced Pluripotent Stem Cells (iPSCs) market in any manner.
Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
FUJIFILM Cellular Dynamics
Takara Bio
Thermo Fisher Scientific
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma
Fate Therapeutics
Cell Inspire Biotechnology
ReproCELL
AcceGen
Market Segmentation (by Type)
Skin
Blood
Others
Market Segmentation (by Application)
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Human Induced Pluripotent Stem Cells (iPSCs) Market
� Overview of the regional outlook of the Human Induced Pluripotent Stem Cells (iPSCs) Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Induced Pluripotent Stem Cells (iPSCs) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Induced Pluripotent Stem Cells (iPSCs), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Induced Pluripotent Stem Cells (iPSCs)
1.2 Key Market Segments
1.2.1 Human Induced Pluripotent Stem Cells (iPSCs) Segment by Type
1.2.2 Human Induced Pluripotent Stem Cells (iPSCs) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Induced Pluripotent Stem Cells (iPSCs) Market Overview
2.1 Global Market Overview
2.1.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Induced Pluripotent Stem Cells (iPSCs) Market Competitive Landscape
3.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Sales by Manufacturers (2019-2025)
3.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Manufacturers (2019-2025)
3.3 Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Induced Pluripotent Stem Cells (iPSCs) Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Human Induced Pluripotent Stem Cells (iPSCs) Sales Sites, Area Served, Product Type
3.6 Human Induced Pluripotent Stem Cells (iPSCs) Market Competitive Situation and Trends
3.6.1 Human Induced Pluripotent Stem Cells (iPSCs) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Induced Pluripotent Stem Cells (iPSCs) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Induced Pluripotent Stem Cells (iPSCs) Industry Chain Analysis
4.1 Human Induced Pluripotent Stem Cells (iPSCs) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Induced Pluripotent Stem Cells (iPSCs) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Induced Pluripotent Stem Cells (iPSCs) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Type (2019-2025)
6.3 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2019-2025)
6.4 Global Human Induced Pluripotent Stem Cells (iPSCs) Price by Type (2019-2025)
7 Human Induced Pluripotent Stem Cells (iPSCs) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Sales by Application (2019-2025)
7.3 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) by Application (2019-2025)
7.4 Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Growth Rate by Application (2019-2025)
8 Human Induced Pluripotent Stem Cells (iPSCs) Market Consumption by Region
8.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.1.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.1.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region
8.2 North America
8.2.1 North America Human Induced Pluripotent Stem Cells (iPSCs) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Induced Pluripotent Stem Cells (iPSCs) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Induced Pluripotent Stem Cells (iPSCs) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Induced Pluripotent Stem Cells (iPSCs) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Human Induced Pluripotent Stem Cells (iPSCs) Market Production by Region
9.1 Global Production of Human Induced Pluripotent Stem Cells (iPSCs) by Region (2019-2025)
9.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Region (2019-2025)
9.3 Global Human Induced Pluripotent Stem Cells (iPSCs) Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Human Induced Pluripotent Stem Cells (iPSCs) Production
9.4.1 North America Human Induced Pluripotent Stem Cells (iPSCs) Production Growth Rate (2019-2025)
9.4.2 North America Human Induced Pluripotent Stem Cells (iPSCs) Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Human Induced Pluripotent Stem Cells (iPSCs) Production
9.5.1 Europe Human Induced Pluripotent Stem Cells (iPSCs) Production Growth Rate (2019-2025)
9.5.2 Europe Human Induced Pluripotent Stem Cells (iPSCs) Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Human Induced Pluripotent Stem Cells (iPSCs) Production (2019-2025)
9.6.1 Japan Human Induced Pluripotent Stem Cells (iPSCs) Production Growth Rate (2019-2025)
9.6.2 Japan Human Induced Pluripotent Stem Cells (iPSCs) Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Human Induced Pluripotent Stem Cells (iPSCs) Production (2019-2025)
9.7.1 China Human Induced Pluripotent Stem Cells (iPSCs) Production Growth Rate (2019-2025)
9.7.2 China Human Induced Pluripotent Stem Cells (iPSCs) Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 FUJIFILM Cellular Dynamics
10.1.1 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
10.1.2 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
10.1.3 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
10.1.4 FUJIFILM Cellular Dynamics Business Overview
10.1.5 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
10.1.6 FUJIFILM Cellular Dynamics Recent Developments
10.2 Takara Bio
10.2.1 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
10.2.2 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
10.2.3 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
10.2.4 Takara Bio Business Overview
10.2.5 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
10.2.6 Takara Bio Recent Developments
10.3 Thermo Fisher Scientific
10.3.1 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
10.3.2 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
10.3.3 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
10.3.4 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
10.3.5 Thermo Fisher Scientific Business Overview
10.3.6 Thermo Fisher Scientific Recent Developments
10.4 Ncardia
10.4.1 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
10.4.2 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
10.4.3 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
10.4.4 Ncardia Business Overview
10.4.5 Ncardia Recent Developments
10.5 Sumitomo Dainippon Pharma
10.5.1 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
10.5.2 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
10.5.3 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
10.5.4 Sumitomo Dainippon Pharma Business Overview
10.5.5 Sumitomo Dainippon Pharma Recent Developments
10.6 Astellas Pharma
10.6.1 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
10.6.2 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
10.6.3 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
10.6.4 Astellas Pharma Business Overview
10.6.5 Astellas Pharma Recent Developments
10.7 Fate Therapeutics
10.7.1 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
10.7.2 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
10.7.3 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
10.7.4 Fate Therapeutics Business Overview
10.7.5 Fate Therapeutics Recent Developments
10.8 Cell Inspire Biotechnology
10.8.1 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
10.8.2 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
10.8.3 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
10.8.4 Cell Inspire Biotechnology Business Overview
10.8.5 Cell Inspire Biotechnology Recent Developments
10.9 ReproCELL
10.9.1 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
10.9.2 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
10.9.3 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
10.9.4 ReproCELL Business Overview
10.9.5 ReproCELL Recent Developments
10.10 AcceGen
10.10.1 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
10.10.2 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
10.10.3 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product Market Performance
10.10.4 AcceGen Business Overview
10.10.5 AcceGen Recent Developments
11 Human Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Region
11.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast
11.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country
11.2.3 Asia Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region
11.2.4 South America Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Human Induced Pluripotent Stem Cells (iPSCs) by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Human Induced Pluripotent Stem Cells (iPSCs) by Type (2025-2032)
12.1.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Human Induced Pluripotent Stem Cells (iPSCs) by Type (2025-2032)
12.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Application (2025-2032)
12.2.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units) Forecast by Application
12.2.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Induced Pluripotent Stem Cells (iPSCs) Market Size Comparison by Region (M USD)
Table 5. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Induced Pluripotent Stem Cells (iPSCs) as of 2022)
Table 10. Global Market Human Induced Pluripotent Stem Cells (iPSCs) Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Human Induced Pluripotent Stem Cells (iPSCs) Sales Sites and Area Served
Table 12. Manufacturers Human Induced Pluripotent Stem Cells (iPSCs) Product Type
Table 13. Global Human Induced Pluripotent Stem Cells (iPSCs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Induced Pluripotent Stem Cells (iPSCs)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Induced Pluripotent Stem Cells (iPSCs) Market Challenges
Table 22. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales by Type (K Units)
Table 23. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (M USD)
Table 24. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units) by Type (2019-2025)
Table 25. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Type (2019-2025)
Table 26. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) by Type (2019-2025)
Table 27. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Type (2019-2025)
Table 28. Global Human Induced Pluripotent Stem Cells (iPSCs) Price (USD/Unit) by Type (2019-2025)
Table 29. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units) by Application
Table 30. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
Table 31. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales by Application (2019-2025) & (K Units)
Table 32. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application (2019-2025)
Table 33. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales by Application (2019-2025) & (M USD)
Table 34. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2019-2025)
Table 35. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Growth Rate by Application (2019-2025)
Table 36. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales by Region (2019-2025) & (K Units)
Table 37. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region (2019-2025)
Table 38. North America Human Induced Pluripotent Stem Cells (iPSCs) Sales by Country (2019-2025) & (K Units)
Table 39. Europe Human Induced Pluripotent Stem Cells (iPSCs) Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Human Induced Pluripotent Stem Cells (iPSCs) Sales by Region (2019-2025) & (K Units)
Table 41. South America Human Induced Pluripotent Stem Cells (iPSCs) Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Human Induced Pluripotent Stem Cells (iPSCs) Sales by Region (2019-2025) & (K Units)
Table 43. Global Human Induced Pluripotent Stem Cells (iPSCs) Production (K Units) by Region (2019-2025)
Table 44. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Region (2019-2025)
Table 46. Global Human Induced Pluripotent Stem Cells (iPSCs) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Human Induced Pluripotent Stem Cells (iPSCs) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Human Induced Pluripotent Stem Cells (iPSCs) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Human Induced Pluripotent Stem Cells (iPSCs) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Human Induced Pluripotent Stem Cells (iPSCs) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 52. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 53. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. FUJIFILM Cellular Dynamics Business Overview
Table 55. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
Table 56. FUJIFILM Cellular Dynamics Recent Developments
Table 57. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 58. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 59. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Takara Bio Business Overview
Table 61. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
Table 62. Takara Bio Recent Developments
Table 63. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 64. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 65. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) SWOT Analysis
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Recent Developments
Table 69. Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 70. Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 71. Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Ncardia Business Overview
Table 73. Ncardia Recent Developments
Table 74. Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 75. Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 76. Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Sumitomo Dainippon Pharma Business Overview
Table 78. Sumitomo Dainippon Pharma Recent Developments
Table 79. Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 80. Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 81. Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Astellas Pharma Business Overview
Table 83. Astellas Pharma Recent Developments
Table 84. Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 85. Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 86. Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Fate Therapeutics Business Overview
Table 88. Fate Therapeutics Recent Developments
Table 89. Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 90. Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 91. Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Cell Inspire Biotechnology Business Overview
Table 93. Cell Inspire Biotechnology Recent Developments
Table 94. ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 95. ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 96. ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. ReproCELL Business Overview
Table 98. ReproCELL Recent Developments
Table 99. AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Basic Information
Table 100. AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product Overview
Table 101. AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. AcceGen Business Overview
Table 103. AcceGen Recent Developments
Table 104. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Region (2025-2032) & (K Units)
Table 105. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Human Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Country (2025-2032) & (K Units)
Table 107. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Human Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Country (2025-2032) & (K Units)
Table 109. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Human Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Region (2025-2032) & (K Units)
Table 111. Asia Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Human Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Country (2025-2032) & (K Units)
Table 113. South America Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Human Induced Pluripotent Stem Cells (iPSCs) Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Type (2025-2032) & (K Units)
Table 117. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Human Induced Pluripotent Stem Cells (iPSCs) Price Forecast by Type (2025-2032) & (USD/Unit)
Table 119. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units) Forecast by Application (2025-2032)
Table 120. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Human Induced Pluripotent Stem Cells (iPSCs)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD), 2019-2032
Figure 5. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (M USD) (2019-2032)
Figure 6. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (M USD)
Figure 11. Human Induced Pluripotent Stem Cells (iPSCs) Sales Share by Manufacturers in 2023
Figure 12. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Manufacturers in 2023
Figure 13. Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Induced Pluripotent Stem Cells (iPSCs) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Induced Pluripotent Stem Cells (iPSCs) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Type
Figure 18. Sales Market Share of Human Induced Pluripotent Stem Cells (iPSCs) by Type (2019-2025)
Figure 19. Sales Market Share of Human Induced Pluripotent Stem Cells (iPSCs) by Type in 2023
Figure 20. Market Size Share of Human Induced Pluripotent Stem Cells (iPSCs) by Type (2019-2025)
Figure 21. Market Size Market Share of Human Induced Pluripotent Stem Cells (iPSCs) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Application
Figure 24. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application (2019-2025)
Figure 25. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application in 2023
Figure 26. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2019-2025)
Figure 27. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Application in 2023
Figure 28. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Growth Rate by Application (2019-2025)
Figure 29. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region (2019-2025)
Figure 30. North America Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country in 2023
Figure 32. U.S. Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Human Induced Pluripotent Stem Cells (iPSCs) Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Human Induced Pluripotent Stem Cells (iPSCs) Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country in 2023
Figure 37. Germany Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region in 2023
Figure 44. China Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (K Units)
Figure 50. South America Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country in 2023
Figure 51. Brazil Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Human Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Human Induced Pluripotent Stem Cells (iPSCs) Production Market Share by Region (2019-2025)
Figure 62. North America Human Induced Pluripotent Stem Cells (iPSCs) Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Human Induced Pluripotent Stem Cells (iPSCs) Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Human Induced Pluripotent Stem Cells (iPSCs) Production (K Units) Growth Rate (2019-2025)
Figure 65. China Human Induced Pluripotent Stem Cells (iPSCs) Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2025-2032)
Figure 70. Global Human Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Application (2025-2032)
Figure 71. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2025-2032)
